Compounds useful in the modulation of klhdc1 and klhdc2 activity

MX2026006216APending Publication Date: 2026-10-02NURIX THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MX2026006216
Authority / Receiving Office
MX · MX
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-21
Filing Date
2026-05-21
Publication Date
2026-10-02
Patent Text Reader

Abstract

This disclosure relates to compounds useful for ex vivo, in vitro, or in vivo modulation of KLHDC1 and KLHDC2 activity. This disclosure also provides pharmaceutically acceptable compositions comprising said compounds, and methods of using the compositions in the treatment of various diseases, conditions, and / or disorders.
Need to check novelty before this filing date? Find Prior Art